BioCentury | Dec 11, 2019
Financial News

Dec. 10 Financial Quick Takes: Inscripta, Aurinia, Akeso, Ribo, Hummingbird, ImmunOs, Peregrine

...new fund will continue to invest in early and late stage medical technology startups; previous Peregrine investments...
BioCentury | Jan 2, 1996
Finance

1995 was a very fine year: Performance pays off

It was a good year. Actually, it was a great year. Biotech companies in 1995 did just about everything biotech companies are supposed to do: they reported outstanding clinical data, they got products approved and...
Items per page:
1 - 2 of 2
BioCentury | Dec 11, 2019
Financial News

Dec. 10 Financial Quick Takes: Inscripta, Aurinia, Akeso, Ribo, Hummingbird, ImmunOs, Peregrine

...new fund will continue to invest in early and late stage medical technology startups; previous Peregrine investments...
BioCentury | Jan 2, 1996
Finance

1995 was a very fine year: Performance pays off

It was a good year. Actually, it was a great year. Biotech companies in 1995 did just about everything biotech companies are supposed to do: they reported outstanding clinical data, they got products approved and...
Items per page:
1 - 2 of 2